Brimonidine Tartrate Solution/ Drops
Product Images NDC 71921-185

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 71921-185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel10ml (10 mL Final)

Carton label for Brimonidine Tartrate Ophthalmic Solution 0.2%, sterile 10 mL drops. The label shows the product name, strength, dosage form, and volume. It is labeled for eye use only, prescription use, and manufactured by Florida Pharmaceutical Products, LLC. The label includes NDC 71921-185, usage, storage, ingredients, warnings, and barcode.*

FDA Label Image

Cartonlabel15ml (15 mL)

Packaging label for Brimonidine Tartrate Ophthalmic Solution 0.2% (2 mg/mL), sterile eye drops in a 15 mL bottle. Label indicates use for the eyes only, includes inactive ingredients and preservative benzalkonium chloride 0.005%. Manufacturer is Florida Pharmaceutical Products, LLC. Contains dosage, storage instructions, and warnings about dropper tip contamination and tear-off ring integrity.*

FDA Label Image

Cartonlabel5ml (5 mL Final)

Brimonidine Tartrate Ophthalmic Solution 0.2% sterile, 5 mL carton from Florida Pharmaceutical Products, LLC. The packaging includes dosage form as solution/drops for ophthalmic use, warnings about dropper tip contamination and tear-off ring, storage instructions, active and inactive ingredients, preservative content, and manufacturer information. The label features the NDC 71921-185. The package is marked Rx Only for use in the eyes.*

FDA Label Image

Str (Active)

Chemical structure of Brimonidine Tartrate, showing its molecular configuration with nitrogen-containing rings and tartrate moieties, consistent with the active ingredient in the ophthalmic solution Brimonidine Tartrate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.